These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2650133)

  • 1. Class II antigens and interleukin 2 expression in renal allograft recipients.
    Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.
    von Willebrand E; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
    Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal target structures in acute allograft rejection.
    Leszczynski D; Laszczynska M; Halttunen J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of class I and class II major histocompatibility complex (MHC) antigens in rejecting human heart grafts.
    Ippoliti G; Lazzaro A; Goggi C; Malavasi F; Di Franco L; Martinelli L; Ascari E; Vigano' M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):445-6. PubMed ID: 2650172
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased detection of class II major histocompatibility complex antigens on blood mononuclear cells from transplant recipients receiving immunosuppressive drugs: influence of cycloheximide and monensin.
    Dupont E; Crusiaux A; Andrien M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):233-4. PubMed ID: 3274775
    [No Abstract]   [Full Text] [Related]  

  • 7. Class II antigen and interleukin-2 expression in renal allograft recipients.
    Nowaczyk M; Lao M; Maldyk M; Morzycka-Michalik M; Paczek L; Modlinska M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1002. PubMed ID: 2650060
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
    McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of fine needle aspiration biopsies from renal transplants using monoclonal antibodies as lymphocyte markers.
    Waugh J; Bishop A; Hall BM; Philips J; Duggin G; Tiller D; Sheil A; Horvath J
    Transplant Proc; 1986 Apr; 18(2):267-9. PubMed ID: 3515663
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell migration between graft and host--an analysis with monoclonal antibodies after allogeneic rat kidney transplantation.
    Krzymański M; Oko A; Waaga AM; Zeromski J; Ulrichs K; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):229-36. PubMed ID: 8744701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation antigen expression on the helper-inducer and cytotoxic-suppressor T cell subpopulations after allogeneic human marrow transplantation.
    Britton K; Atkinson K; Chapman G; Downs K; Biggs JC
    Transplant Proc; 1986 Apr; 18(2):302-4. PubMed ID: 2938318
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes.
    Russ GR; Pascoe V; d'Apice AJ; Seymour AE
    Transplant Proc; 1986 Apr; 18(2):293-7. PubMed ID: 3515666
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of MHC class I and class II antigens in cultured human kidney cells.
    Worlock AJ; Brown S; Horsburgh T; Bell PR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):322. PubMed ID: 2650135
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte subsets in the allograft recipient: correlation of helper to suppressor ratio with clinical events.
    Mazaheri R; Laupacis A; Keown P; Howson W; Sinclair NR; Stiller CR
    Transplant Proc; 1982 Dec; 14(4):676-8. PubMed ID: 6220494
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.
    Deierhoi MH; Radvany RM; Wolf JS
    Transplant Proc; 1981 Mar; 13(1 Pt 2):942-4. PubMed ID: 7022966
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue distribution of MHC class II--positive cells, their down-manipulation by monoclonal antibodies and potential role in organ allograft immunogenicity.
    Krzymański M; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):177-81. PubMed ID: 1300981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.